Bridging integrator 1 (BIN1) protein expression increases in the alzheimer's disease brain and correlates with neurofibrillary tangle pathology

Journal of Alzheimer's Disease

Volumn 42, Issue 4, 2014, Pages 1221-1227

  Holler, Christopher J ^a   Davis, Paulina R ^a,b   Beckett, Tina L ^a   Platt, Thomas L ^a   Webb, Robin L ^a   Head, Elizabeth ^a,b   Murphy, M Paul ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; amyloid peptide; cellular nucleic acid binding protein; myotonic dystrophy; tau; ZNF9

Indexed keywords

AMPHIPHYSIN; AMYLOID BETA PROTEIN; BRIDGING INTEGRATOR 1 PROTEIN; ISOPROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; BIN1 PROTEIN, HUMAN; MAPT PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFERIOR TEMPORAL CORTEX; MAJOR CLINICAL STUDY; MALE; MIDDLE TEMPORAL GYRUS; NEUROFIBRILLARY TANGLE; PARIETAL CORTEX; PROTEIN EXPRESSION; SENILE PLAQUE; SUPERIOR TEMPORAL GYRUS; AMYLOID PLAQUE; BRAIN; IMMUNOHISTOCHEMISTRY; ISOMERISM; METABOLISM; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR CELL LINE; VERY ELDERLY; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BLOTTING, WESTERN; BRAIN; CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOMERISM; MALE; NEUROFIBRILLARY TANGLES; NUCLEAR PROTEINS; PLAQUE, AMYLOID; TAU PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84907992358     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132450     Document Type: Article

References (37)

1. Niedowicz DM, Nelson PT, Murphy MP (2011) Alzheimer's disease: Pathological mechanisms and recent insights. Curr Neuropharmacol 9, 674-684.
2. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dich-gans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variantsat CLU and PICALM associated with Alzheimer's disease. Nat Genet 41, 1088-1093.
3. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tav-ernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Pic-cardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alperovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41, 1094-1099.
4. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gud-nason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, Harold D, Schrijvers EM, Ramirez-Lorca R, Debette S, Longstreth WT Jr, Janssens AC, Pankratz VS, Dar-tigues JF, Hollingworth P, Aspelund T, Hernandez I, Beiser A, Kuller LH, Koudstaal PJ, Dickson DW, Tzourio C, Abraham R, Antunez C, Du Y, Rotter JI, Aulchenko YS, Harris TB, Petersen RC, Berr C, Owen MJ, Lopez-Arrieta J, Varadara-jan BN, Becker JT, Rivadeneira F, Nalls MA, Graff-Radford NR, Campion D, Auerbach S, Rice K, Hofman A, Jonsson PV, Schmidt H, Lathrop M, Mosley TH, Au R, Psaty BM, Uitterlinden AG, Farrer LA, Lumley T, Ruiz A, Williams J, Amouyel P, Younkin SG, Wolf PA, Launer LJ, Lopez OL, van Duijn CM, Breteler MM (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303, 1832-1840.
5. Sakamuro D, Elliott KJ, Wechsler-Reya R, Prendergast GC (1996) BIN1isa novel MYC-interacting protein with features of a tumour suppressor. Nat Genet 14, 69-77.
6. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH (1996) Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56, 3091-3102.
7. Ren G, Vajjhala P, Lee JS, Winsor B, Munn AL (2006) The BAR domain proteins: Molding membranes in fission, fusion, and phagy. Microbiol Mol Biol Rev 70, 37-120.
8. Itoh T, De Camilli P (2006) BAR, F-BAR (EFC) and ENTH/ANTH domains in the regulation of membrane-cytosol interfaces and membrane curvature. Biochim Biophys Acta 1761, 897-912.
9. Dowling JJ, Gibbs EM, Feldman EL (2008) Membrane traffic and muscle: Lessons from human disease. Traffic 9, 1035-1043.
10. Glennon EB, Whitehouse IJ, Miners JS, Kehoe PG, Love S, Kellett KA, Hooper NM (2013) BIN1Is decreasedin sporadic but not familial Alzheimer's disease or in aging. PLoS One 8, e78806.
11. Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, Geller F, Sottejeau Y, Harold D, Dourlen P, Grenier-Boley B, Kamatani Y, Delepine B, Demi-autte F, Zelenika D, Zommer N, Hamdane M, Bellenguez C, Dartigues JF, Hauw JJ, Letronne F, Ayral AM, Sleegers K, Schellens A, Broeck LV, Engelborghs S, De Deyn PP, Van-denberghe R, O'Donovan M, Owen M, Epelbaum J, Mercken M, Karran E, Bantscheff M, Drewes G, Joberty G, Campion D, Octave JN, Berr C, Lathrop M, Callaerts P, Mann D, Williams J, Buee L, Dewachter I, Van Broeckhoven C, Amouyel P, Moechars D, Dermaut B, Lambert JC (2013) Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry 18, 1225-1234.
12. Fugier C, Klein AF, Hammer C, Vassilopoulos S, Ivarsson Y, Toussaint A, Tosch V, Vignaud A, Ferry A, Messaddeq N, Kokunai Y, Tsuburaya R, delaGrange P, Dembele D, Francois V, Precigout G, Boulade-Ladame C, Hummel MC, deMunain AL, Sergeant N, Laquerriere A, Thibault C, Deryckere F, Auboeuf D, Garcia L, Zimmermann P, Udd B, Schoser B, Takahashi MP, Nishino I, Bassez G, Laporte J, Furling D, Charlet-Berguerand N (2011) Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat Med 17, 720-725.
13. Wang Y, Wang J, Gao L, Lafyatis R, Stamm S, Andreadis A (2005) Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c. SRp55 complex that either recruits or antagonizes htra2beta1. J Biol Chem 280, 14230-14239.
14. Leroy O, Wang J, Maurage CA, Parent M, Cooper T, Buee L, Sergeant N, Andreadis A, Caillet-Boudin ML (2006) Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1. Biochim Biophys Acta 1762, 460-467.
15. Dhaenens CM, Tran H, Frandemiche ML, Carpentier C, Schraen-Maschke S, Sistiaga A, Goicoechea M, Eddarkaoui S, Van Brussels E, Obriot H, Labudeck A, Gevaert MH, Fernandez-Gomez F, Charlet-Berguerand N, Deramecourt V, Maurage CA, Buee L, de Munain AL, Sablonniere B, Caillet-Boudin ML, Sergeant N (2011) Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpres-sionofCELF2 but notbyMBNL1 silencing. Biochim Biophys Acta 1812, 732-742.
16. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegener-ative tauopathies. Annu Rev Neurosci 24, 1121-1159.
17. Maurage CA, Udd B, Ruchoux MM, Vermersch P, Kalimo H, Krahe R, Delacourte A, Sergeant N (2005) Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 65, 1636-1638.
18. Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C, Schneider-Gold C, Betz RC, Helmstaedter C, Tittgemeyer M, Klockgether T, Kornblum C (2011) The brain in myotonic dystrophy 1 and 2: Evidence for a predominant white matter disease. Brain 134, 3530-3546.
19. Lusis AJ, Rajavashisth TB, Klisak I, Heinzmann C, Mohandas T, Sparkes RS (1990) Mapping of the gene for CNBP, a finger protein, tohuman chromosome 3q13.3-q24.Genomics 8, 411-414.
20. Holler CJ, Webb RL, Laux AL, Beckett TL, Niedowicz DM, Ahmed RR, Liu Y, Simmons CR, Dowling AL, Spinelli A, Khurgel M, Estus S, Head E, Hersh LB, Murphy MP (2012) BACE2 expressionincreasesinhuman neurodegenerative disease. Am J Pathol 180, 337-350.
21. Beckett TL, Webb RL, Niedowicz DM, Holler CJ, Matveev S, Baig I, LeVine H, 3rd, Keller JN, Murphy MP (2012) Postmortem Pittsburgh compound B (PiB) binding increases with Alzheimer's disease progression. J Alzheimers Dis 32, 127-138.
22. Niedowicz DM, Beckett TL, Matveev S, Weidner AM, Baig I, Kryscio RJ, Mendiondo MS, LeVine H, 3rd, Keller JN, Murphy MP (2012) Pittsburgh compound B and the postmortem diagnosis of Alzheimer disease. Ann Neurol 72, 564-570.
23. Murphy MP, Beckett TL, Ding Q, Patel E, Markesbery WR, St Clair DK, LeVine H, 3rd, Keller JN (2007) Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice. Neurobiol Dis 27, 301-311.
24. Niedowicz DM, Beckett TL, Holler CJ, Weidner AM, Murphy MP (2010) APP (DeltaNL695) expression in murine tissue downregulates CNBP expression. Neurosci Lett 482, 57-61.
25. Saing T, Dick M, Nelson PT, Kim RC, Cribbs DH, Head E (2012) Frontal cortex neuropathology in dementia pugilistica. J Neurotrauma 29, 1054-1070.
26. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6, 65-70.
27. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, NAylor SL, Day JW, Ranum LPW (2001) Mytotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293, 864-867.
28. Jones K, Jin B, Iakova P, Huichalaf C, Sarkar P, Schneider-Gold C, Schoser B, Meola G, Shyu AB, Timchenko N, Timchenko L (2011) RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2. Am J Pathol 179, 2475-2489.
29. Sammons MA, Antons AK, Bendjennat M, Udd B, Krahe R, Link AJ (2010) ZNF9 activationofIRES-mediated translation of the human ODC mRNAisdecreased in myotonic dystrophy type 2. PloS One 5, e9301.
30. Huichalaf C, Schoser B, Schneider-Gold C, Jin B, Sarkar P, Timchenko L (2009) Reduction of the rate of protein translation in patients with myotonic dystrophy 2. J Neurosci 29, 9042-9049.
31. Gerbasi VR, Link AJ (2007) The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation. Mol Cell Proteomics 6, 1049-1058.
32. Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM (2012) Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains. PLoS One 7, e50976.
33. Sun L, Tan MS, Hu N, Yu JT, Tan L (2013) Exploring the value of plasma BIN1 as a potential biomarker for Alzheimer's disease. J Alzheimers Dis 37, 291-295.
34. Kauwe JS, Cruchaga C, Karch CM, Sadler B, Lee M, Mayo K, Latu W, Su'a M, Fagan AM, Holtzman DM, Morris JC, Alzheimer's Disease Neuroimaging I, Goate AM (2011) Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease. PLoS One 6, e15918.
35. Thomas RS, Lelos MJ, Good MA, Kidd EJ (2011) Clathrin-mediated endocytic proteins are upregulated in the cortex of the Tg2576 mouse model ofAlzheimer's disease-like amyloid pathology. Biochem Biophys Res Commun 415, 656-661.
36. Pant S, Sharma M, Patel K, Caplan S, Carr CM, Grant BD (2009) AMPH-1/Amphiphysin/Bin1 functions with RME-1/Ehd1 in endocytic recycling. Nat Cell Biol 11, 1399-1410.
37. Meunier B, Quaranta M, Daviet L, Hatzoglou A, Leprince C (2009) The membrane-tubulating potential of amphiphysin 2/BIN1 is dependent on the microtubule-binding cytoplasmic linker protein 170 (CLIP-170). Eur J Cell Biol 88, 91-102.